By: Aaron Kirchfeld, Nishant Kumar, Eyk Henning
(Bloomberg) -- Bluebell Capital Partners, the European activist investment firm, is shutting down its hedge fund after targeting high-profile companies from pharmaceutical giant GSK Plc to luxury conglomerate Richemont.